RN7SL735P

Across TCGA pan-cancer cohorts, RN7SL735P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RN7SL735P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RN7SL735P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL735P is over-expressed in tumor, although a few such as BRCA and LUSC show the opposite, repressed pattern.

STAD, BRCA, and LUSC are the cancer types where RN7SL735P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL735P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.206	.006	4	view →
BRCA	All	III,IV	−0.035	.048	2	view →
LUSC	All	II,III,IV	−0.081	.017	1	view →
LIHC	Female	All	+0.045	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RN7SL735P–STAD

Open the STAD breakdown →